ArticleEsophagus : official journal of the Japan Esophageal Society2026
Acid bile salt induces esophageal mucosal barrier dysfunction through miR-146a-5p-KYNU pathway in gastroesophageal reflux disease.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decoding miRNA‑146a: Mechanisms of action in cardiovascular diseases and endocrine metabolic disorders (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundGastroesophageal reflux disease (GERD) is a common digestive disease characterized by impaired esophageal mucosal barrier integrity. Growing evidence indicated that mucosal barrier dysfunction of GERD might be attributed to esophageal inflammation, rather than direct chemical damage of acidic refluxates. However, the potential mechanisms underlying the activation of esophageal inflammation in GERD remain unclear.
methodsPatients with GERD symptoms (gastroesophageal reflux disease [GERD] and functional esophageal disorders [FED]) and healthy volunteers were prospectively enrolled. GERD-specific miRNA-mRNA pairs were identified and subsequently validated through histological examination and in vitro experiments. The human esophageal epithelial cell (HEEC) line was used to explore the specific mechanism contributing to the mucosal barrier dysfunction.
resultsBoth miR-146a-5p and its target mRNA, KYNU, were significantly up-regulated in GERD compared with FED/healthy volunteers. In vitro, miR-146a-5p overexpression led to a marked increase in KYNU and interleukin-6 (IL-6) expression, accompanied by a decrease in claudin-4 level and dilated intercellular spaces (DIS). Acid bile salt (ABS) stimulation, mimicking the reflux of GERD, could lead to up-regulation of miR-146a-5p and KYNU in HEECs, which resulted in up-regulation of IL-6 and down-regulation of claudin-4, eventually causing DIS. These effects were mitigated by inhibiting miR-146a-5p or KYNU.
conclusionThis study provided novel insights into how acidic refluxates drove inflammation damage to esophageal barrier integrity in GERD. By modulating GERD-specific pair miR-146a-5p-KYNU, acidic refluxates could promote IL-6 secretion, leading to claudin-4 down-regulation and DIS, ultimately impairing esophageal barrier integrity in GERD.
Indexed as
Identifiers
41703371What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.